GEE & URSULA

‘Don’t pop the champagne’ for Pfizer’s COVID vaccine yet, warns virologist

Nov 9, 2020, 12:30 PM | Updated: Oct 3, 2024, 7:57 am

What does Monday’s announcement from Pfizer regarding a potential COVID vaccine mean long-term? Columbia University virologist Dr. Angela Rasmussen, a weekly guest of KIRO Radio’s Gee & Ursula Show, offered some context on Twitter.

Pfizer said early data indicates that its COVID vaccine has proven effective in over 90% of its trial participants.

“We need any vaccine as soon as possible, but I’m pretty skeptical that this vaccine is going to be the ‘winner’ of the vaccine race,” Rasmussen said.

Virologist: We need to adjust expectations for the COVID vaccine

While Pfizer’s vaccine saw a “big reduction in symptoms” for 90% of its participants, Dr. Rasmussen said, “it’s not clear that this vaccine is effective at preventing infection altogether.” A reduction in symptoms is beneficial, but it’s different than a reduction in new cases, she explained.

“People who don’t get infected at all will not be able to potentially transmit the virus to others. People who have less symptomatic disease won’t be overwhelming hospitals and dying, but if they get infected they may still be able to transmit to others,” Rasmussen added.

She also says that while this is a huge finding that will save lives if it holds, there is still a lot of coordination needed before enough of the population is vaccinated that we wouldn’t have to worry about transmission from vaccinated to non-vaccinated people “without the same protection against severe disease.” This process could be even longer, she warns, if people are hesitant to get the vaccine or if access is limited.

Overall, she advises “cautious optimism,” and points out that “this news does not mean we are on the verge of ‘ending the pandemic.'”

Risk of getting COVID-19 today ‘higher than it’s ever been’

“If the data supports this it’s a big milestone but not the final milestone,” she said. “There’s still a long road ahead. Manage your expectations.”

On Tuesday, Dr. Rasmussen joined the Gee & Ursula Show and reiterated some of what she had expressed on Twitter. Listen to the whole interview below:

Gee & Ursula

amazon acquisition AI...

Gee Scott and Ursula Reutin Show

‘How big’s too big?’: Spike raises concerns about Amazon’s reach as the company reportedly pursues another AI acquisition

Ursula Reutin questions Amazon's potential $7 billion acquisition of AI startup Decart amid rising concerns about its market influence.

15 hours ago

seattle restaurant close...

Gee Scott and Ursula Reutin Show

‘It’s taking everything from me’: Pam’s Kitchen owner details rising costs behind Seattle restaurant’s closure

After 20 years, Pam's Kitchen in Seattle closes due to debt and rising costs, highlighting challenges faced by local restaurants.

15 hours ago

cross-country camas...

Gee Scott and Ursula Reutin Show

‘This act right here is selfish’: Gee and Ursula criticize WIAA after Camas cross-country meet moved

A Southwest Washington high school cross-country championship is being moved because of safety concerns surrounding a transgender runner.

1 day ago

Sam Darnold #14 of the Seattle Seahawks looks on prior to the game against the Denver Broncos at Em...

Gee Scott

Gee: Wait, what?! Are we really going to turn on Sam Darnold?

Sam Darnold deserves grace. Seahawks fans, don't forget what he just did for us.

1 day ago

pay parking sign...

Gee Scott and Ursula Reutin Show

‘An expensive little trip’: Gee and Ursula say parking costs already sting as mayor’s budget proposes higher tax

Gee and Ursula react to Seattle Mayor Katie Wilson's proposed budget, which would raise the commercial parking tax to 17%.

2 days ago

camas trans student race...

Ursula Reutin

Ursula: Allowing a trans student to race against girls in Camas only fuels hate toward the trans community

About a dozen girls on the Camas High School cross-country team refused to race this week because a transgender teammate was competing in the girls' division.

2 days ago

‘Don’t pop the champagne’ for Pfizer’s COVID vaccine yet, warns virologist